OvAge: A new methodology to quantify ovarian reserve combining clinical, biochemical and 3D-ultrasonographic parameters

Journal of Ovarian Research

Volumn 8, Issue 1, 2015, Pages

  Venturella, Roberta ^a   Lico, Daniela ^a   Sarica, Alessia ^a   Falbo, Maria Pia ^a   Gulletta, Elio ^a   Morelli, Michele ^a   Zupi, Errico ^b   Cevenini, Gabriele ^b   Cannataro, Mario ^a   Zullo, Fulvio ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

3D Antral Follicle Count; Anti M llerian Hormone; Distance to menopause; Family planning; Follicle Stimulating Hormone; Generalized linear model; Ovarian reserve; Reproduction

Indexed keywords

ESTRADIOL; FOLLITROPIN; MUELLERIAN INHIBITING FACTOR;

ADULT; AGE; ANTRAL FOLLICLE COUNT; ARTICLE; BLOOD FLOW; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; FEMALE FERTILITY; FEMALE GENITAL TRACT PARAMETERS; FOLLITROPIN BLOOD LEVEL; HUMAN; IMAGING SOFTWARE; MAJOR CLINICAL STUDY; MENOPAUSE; MENSTRUAL CYCLE; OBSERVATIONAL STUDY; OVARIAN AGE; OVARIAN RESERVE; OVARY FOLLICLE; OVARY FUNCTION; OVARY POLYCYSTIC DISEASE; OVARY VOLUME; PARITY; PREMATURE OVARIAN FAILURE; PRIORITY JOURNAL; REAL TIME ULTRASOUND SCANNER; REPRODUCTION; STATISTICAL MODEL; THREE DIMENSIONAL IMAGING; VASCULARIZATION; BLOOD; DIAGNOSTIC IMAGING; ENZYME LINKED IMMUNOSORBENT ASSAY; MIDDLE AGED; OVARY; PATHOPHYSIOLOGY; PHYSIOLOGY; YOUNG ADULT;

ADULT; ANTI-MULLERIAN HORMONE; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; IMAGING, THREE-DIMENSIONAL; LINEAR MODELS; MIDDLE AGED; OVARIAN RESERVE; OVARY; POLYCYSTIC OVARY SYNDROME; PRIMARY OVARIAN INSUFFICIENCY; ULTRASONOGRAPHY; YOUNG ADULT;

EID: 84927135176     PISSN: None     EISSN: 17572215     Source Type: Journal    
DOI: 10.1186/s13048-015-0149-z     Document Type: Article

References (22)

1. Ferrell RJ, O'Connor KA, Holman DJ, Brindle E, Miller RC, Rodriguez G, et al. Monitoring reproductive aging in a 5-year prospective study: aggregate and individual changes in luteinizing hormone and follicle-stimulating hormone with age. Menopause. 2007;14:29-37.
2. Navot D, Rosenwaks Z, Margalioth EJ. Prognostic assessment of female fecundity. Lancet. 1987;2:645-7.
3. American College of Obstetricians and Gynecologists. Ovarian reserve testing. Committee Opinion No. 618. Obstet Gynecol. 2015;125:268-73.
4. Sun W, Stegmann BJ, Henne M, Catherino WH, Segars JH. A new approach to ovarian reserve testing. Fertil Steril. 2008;90:2196-202.
5. Beck-Peccoz P, Persani L. Premature ovarian failure. Orphanet J Rare Dis. 2006;6:1-9.
6. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81:19-25.
7. Mulders AG, Laven JS, Eijkemans MJ, de Jong FH, Themmen AP, Fauser BC. Changes in anti-Müllerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility. Hum Reprod. 2004;19:2036-42.
8. Deb S, Campbell BK, Clewes JS, Raine-Fenning NJ. Quantitative analysis of antral follicle number and size: a comparison of two-dimensional and automated three-dimensional ultrasound techniques. Ultrasound Obstet Gynecol. 2010;35:354-60.
9. Cole TJ, Green PJ. Smoothing reference centile curves: the LMS method and penalized likelihood. Statist Med. 1992;11:1305-19.
10. Akaike H. A new look at the statistical model identification. IEEE Trans Automat Contr. 1974;19:716e723.
11. Tehrani FR, Solaymani-Dodaran M, Tohidi M, Gohari MR, Azizi F. Modeling age at menopause using serum concentration of anti-mullerian hormone. J Clin Endocrinol Metab. 2013;98:729-35.
12. Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update. 2006;12:685-718.
13. Bancsi LF, Broekmans FJ, Mol BW, Habbema JD, Te Velde ER. Performance of basal follicle-stimulating hormone in the prediction of poor ovarian response and failure to become pregnant after in vitro fertilization: a meta-analysis. Fertil Steril. 2003;79:1091-100.
14. van Rooij IA, Broekmans FJ, te Velde ER, Fauser BC, Bancsi LF, de Jong FH, et al. Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve. Hum Reprod. 2002;17:3065-71.
15. Seifer DB, Baker VL, Leader B. Age-specific serum anti-Müllerian hormone values for 17,120 women presenting to fertility centers within the United States. Fertil Steril. 2011;95:747-50.
16. Hussain M, Cahill D, Akande V, Gordon U. Discrepancies between Antimullerian Hormone and Follicle Stimulating Hormone in Assisted Reproduction. Obstet Gynecol Int. 2013;2013:383278.
17. Iliodromiti S, Kelsey TW, Wu O, Anderson RA, Nelson SM. The predictive accuracy of anti-Mullerian hormone for live birth after assisted conception: a systematic review and meta-analysis of the literature. Hum Reprod Update. 2014;20:560-70.
18. Dewailly D, Andersen CY, Balen A, Broekmans F, Dilaver N, Fanchin R, et al. The physiology and clinical utility of anti-Mullerian hormone in women. Hum Reprod Update. 2014;20:370-85.
19. Hendriks DJ, Mol BW, Bancsi LF, Te Velde ER, Broekmans FJ. Antral follicle count in the prediction of poor ovarian response and pregnancy after in vitro fertilization: a meta-analysis and comparison with basal follicle-stimulating hormone level. Fertil Steril. 2005;83:291-301.
20. Gibreel A, Maheshwari A, Bhattacharya S, Johnson NP. Ultrasound tests of ovarian reserve; a systematic review of accuracy in predicting fertility outcomes. Hum Fertil (Camb). 2009;12:95-106.
21. Kim SH, Lee JM, Kim YJ, Lee JY, Han JK, Choi BI. High-definition flow Doppler ultrasonographic technique to assess hepatic vasculature compared with color or power Doppler ultrasonography: preliminary experience. J Ultrasound Med. 2008;27:1491-501.
22. Van Blerkom J, Antczak M, Schrader R. The developmental potential of the human oocyte is related to the dissolved oxygen content of follicular fluid: association with vascular endothelial growth factor levels and perifollicular blood flow characteristics. Hum Reprod. 1997;12:1047-55.